Because BRCA1 and BRCA2 mutation carriers are susceptible to a much higher risk of breast cancer than non-carriers, the corresponding absolute differences in risk between parous and nulliparous carriers may be substantial. The gene discussed is BRCA2; the disease is breast carcinoma.